Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03810846
Other study ID # ISPUP-RMFIFA2018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 17, 2018
Est. completion date June 30, 2019

Study information

Verified date August 2019
Source Universidade do Porto
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Our main challenge is to develop a novel physical activity intervention to promote exercise participation sustainability and effective health benefits in type 2 diabetes (T2D) population with minimum health risks. The relevance of this study is supported by four cornerstones: 1) The Portuguese love football and there seems to be a major potential in the implementation of football practice as part of the prevention and treatment of noncommunicable diseases for the middle-aged and elderly Portuguese population; 2) no studies have assessed the feasibility and safety of a walking football exercise program for middle-age and older patients with T2D; 3) the proposed investigation relies on robust methodology; 4) this intervention can have further sustainability with the enrollment of football clubs and primary health care units.


Description:

This work will be a quasi-experimental study where we aim to test the feasibility and safety of walking football in patients with T2D. The recruitment of participants will be held in primary health care units by Family Medicine medical doctors. All participants will receive instructions to maintain daily-life routines (lifestyle-related physical activity and dietary pattern), and to continue with usual care (diabetes consultations on primary health care units and pharmacological regimen) along the studies duration. All participants will receive basic sports material (sports bag, T-shirt, and sports shoes). Participants will be organized in two teams of 20 players. Each team will have 60-min walking football exercise sessions three times per week (non-consecutive days), during three months (36 sessions). Different walking football exercise strategies will be developed according to participants' motor skills and tested with dose-escalated intensity for its safety (acute effects on capillary glycaemia, blood pressure, foot impact, exercise-related injuries and adverse events) and enjoyment. Exercise intensity will range between light to vigorous. No submaximal or maximal exercises will be tested. Cumulative short-term effects will also be analyzed along the three months through pre- and post-study evaluations. Exercise sessions will be conducted on a sports hall (indoor court) by a football coach and supervised by an exercise physiologist and a nurse.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date June 30, 2019
Est. primary completion date January 31, 2019
Accepts healthy volunteers No
Gender Male
Age group 50 Years to 70 Years
Eligibility Inclusion Criteria:

- diagnosis of type 2 diabetes for at least 12 months;

- glycated hemoglobin bellow 10 %;

- not having started insulin therapy in the previous six months;

- not having started therapy with sulfonylureas in the previous six months;

- major complications of diabetes screened and controlled (diabetic retinopathy, diabetic nephropathy and diabetic foot);

- no symptoms of coronary artery disease;

- no cardiovascular, respiratory and musculoskeletal contraindications to exercise;

- not under cancer treatment (radiotherapy or intravenous chemotherapy);

- without limitations in gait or balance;

- independent living in the community;

- not engaged in supervised exercise;

- non-smokers at least for 6 months.

Exclusion Criteria:

- cardiological stress test with cardiac or hemodynamic problems

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Walking football exercise program
Participants will be organized in two teams of 20 players. Each team will have 60-min walking football exercise sessions three times per week (non-consecutive days), during three months (36 sessions). Different walking football exercise strategies will be developed according to participants' motor skills and tested with dose-escalated intensity for its safety and enjoyment. Exercise intensity will range between light to vigorous. No submaximal or maximal exercises will be tested. Exercise sessions will be conducted on a sports hall (indoor court) by a football coach and supervised by an exercise physiologist and a nurse.

Locations

Country Name City State
Portugal Instituto de Saúde Pública da Universidade do Porto Porto

Sponsors (4)

Lead Sponsor Collaborator
Universidade do Porto Administração Regional de Saúde do Norte, Portugal, Federação Portuguesa de Futebol, Portugal, Fédération Internationale de Football Association

Country where clinical trial is conducted

Portugal, 

References & Publications (4)

Barbosa A, Brito J, Costa J, Ramos E, Firmino-Machado J, Seabra A, Figueiredo P, Sá MJ, Lunet N, Mendes R. SWEET-FOOTBALL: Development of an evidence-based walking football program for middle-aged and older patients with type 2 diabetes. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: University of Southern Denmark; 2019. p. 32.

Barbosa A, Brito J, Sá MJ, Puga F, Firmino-Machado J, Seabra A, Figueiredo P, Ramos E, Lunet N, Mendes R. Adherence and enjoyment of a walking-football program for patients with type 2 diabetes: SWEET-FOOTBALL Project. In: Bunc V, Tsolakidis E, editors. B

Costa J, Brito J, Barbosa A, Figueiredo P, Seabra A, Sá MJ, Firmino-Machado J, Ramos E, Mendes R. Nocturnal cardiac autonomic activity in patients with type 2 diabetes engaged in a walking football programme. Football is Medicine Conference 2019 - Program

Rago V, Brito J, Costa J, Barbosa A, Figueiredo P, Seabra A, Travassos B, Mendes R. Activity profile during walking football training sessions in patients with type 2 diabetes. Football is Medicine Conference 2019 - Programme and Abstracts. Odense: Univer

Outcome

Type Measure Description Time frame Safety issue
Primary Exercise intensity - subjective internal load OMNI rating of perceived exertion scale during exercise (0 [lowest] to 10 [highest] points) Through 3 months
Primary Exercise intensity - objective internal load Heart rate during exercise Through 3 months
Primary Exercise intensity - external load Distance (km) assessed using GPS tracking during exercise Through 3 months
Primary Acute glycemic effect Acute change in capillary blood glucose with exercise sessions Change between before and immediately after each exercise session
Primary Acute systolic blood pressure effect Acute change in systolic blood pressure with exercise sessions Change between before and immediately after each exercise session
Primary Acute diastolic blood pressure effect Acute change in diastolic blood pressure with exercise sessions Change between before and immediately after each exercise session
Primary Incidence of falls Number of falls during the exercise program Through 3 months
Primary Incidence of foot injuries Number of reported foot injuries during the exercise program Through 3 months
Primary Incidence of musculoskeletal injuries Number of reported musculoskeletal injuries during the exercise program Through 3 months
Primary Rate of Enjoyment Self-reported exercise sessions' enjoyment on a likert scale (1 [lowest] to 5 [highest] points) Through 3 months
Secondary Glycemic control Glycated hemoglobin (venous blood analysis) Change from baseline to 3 months
Secondary Blood lipid profile Total cholesterol (venous blood analysis) Change from baseline to 3 months
Secondary Clinical systolic blood pressure Resting systolic blood pressure Change from baseline to 3 months
Secondary Clinical diastolic blood pressure Resting diastolic blood pressure Change from baseline to 3 months
Secondary Body mass index Body mass index Change from baseline to 3 months
Secondary Waist circumference Waist circumference Change from baseline to 3 months
Secondary Body fat Body fat (bioelectrical impedance analysis) Change from baseline to 3 months
Secondary Body lean mass Body lean mass (bioelectrical impedance analysis) Change from baseline to 3 months
Secondary Agility/balance Timed Up and Go Test Change from baseline to 3 months
Secondary Habitual physical activity Global Physical Activity Questionnaire Change from baseline to 3 months
Secondary Food pattern 24h-food recall analysis Change from baseline to 3 months
Secondary Cognitive state Montreal Cognitive Assessment score (0 [lowest] to 30 [highest] points) Change from baseline to 3 months
Secondary Health-related quality of life EQ-5D-5L questionnaire score (0 [lowest] to 100 [highest] points) Change from baseline to 3 months
Secondary Medication Number of medications Change from baseline to 3 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Completed NCT05647083 - The Effect of Massage on Diabetic Parameters N/A
Active, not recruiting NCT05661799 - Persistence of Physical Activity in People With Type 2 Diabetes Over Time. N/A
Completed NCT03686722 - Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin Phase 1
Completed NCT02836704 - Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose) Phase 4
Completed NCT01819129 - Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes Phase 3
Completed NCT04562714 - Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy N/A
Completed NCT02009488 - Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM) Phase 1
Completed NCT05896319 - Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2 N/A
Recruiting NCT05598203 - Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes N/A
Completed NCT05046873 - A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People Phase 1
Terminated NCT04090242 - Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes N/A
Completed NCT04030091 - Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus Phase 4
Completed NCT03620357 - Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D) N/A
Completed NCT03604224 - A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
Completed NCT01696266 - An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
Completed NCT03620890 - Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy Phase 4
Withdrawn NCT05473286 - A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
Not yet recruiting NCT05029804 - Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes N/A
Completed NCT04531631 - Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes Phase 2